Maya-Biotech is focusing its efforts on forging strategic alliances and building relationships with medical device and pharmaceutical players in the Oral Drug Delivery (ODD), reconstitution and pharmaceutical segments.
Anadis
Anadis is a publicly traded Australian biotechnology company (ASX: ANX; OTC: ANDIY) with proprietary immunotherapeutic technology and a product pipeline based on primed colostrums (bovine colostrums from cows immunized against specific targets) containing targeted polyclonal antibodies and other proteins, addressing a range of gastrointestinal infections and immune-mediated diseases.
Website: www.anadis.com
|
Development by Mixermedia 